Generic Name: Repaglinide 0.5 mg
Manufacturer/Distributor: Pacific Pharmaceuticals Ltd.
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Indications
In patients with type 2 diabetes mellitus (NIDDM) whose hyperglycemia cannot be controlled adequately by diet and exercise alone, repaglinide is used as an addition to diet and exercise to lower blood glucose. It's also approved for use with Metformin to help individuals with hyperglycemia who can't control their blood sugar with exercise, diet, or either Repaglinide or Metformin alone.
Pharmacology
Repaglinide binds to specific receptors in the cell membrane, causing ATP-dependent K+ channels to close and the cell membrane to depolarize. This results in Ca++ inflow, increased intracellular Ca++, and insulin secretion stimulation.
Dosage & Administration
For patients not previously treated or whose HbA1c is <8%, the starting dose should be 0.5 mg before each meal.
For patients previously treated with blood glucose-lowering drugs and whose HbA1c is >8%, the initial dose is 1 or 2 mg before each meal.
Repaglinide should be taken immediately or up to 30 minutes before each meal.
Dosage should be adjusted according to response at intervals of 1-2 weeks; up to 4 mg may be given as a single dose, a maximum of 16 mg daily.
Contraindications
Diabetic ketoacidosis, with or without coma, is contraindicated in individuals using repaglinide.
Diabetes mellitus type 1 and a history of hypersensitivity to the medication or its inactive components.
Side Effects
Hypoglycemia and associated symptoms are the most common Repaglinide adverse effects. Upper respiratory infections, diarrhea, constipation, nausea, and vomiting are among the other symptoms. Rashes and urticaria are examples of hypersensitivity reactions.
Pregnancy & Lactation
There is no evidence of safety in pregnant women. Repaglinide should only be taken during pregnancy if it is absolutely necessary. Repaglinide is not known to be excreted in human milk. Because many medications are excreted in human milk and because Repaglinide can cause major adverse reactions in nursing infants, a choice should be made whether to stop breastfeeding or stop taking the drug, taking into account the drug's importance to the mother.
Precautions & Warnings
Affront ought to be substituted amid concurrent sickness (such as myocardial dead tissue, coma, disease, and injury) and amid surgery. All verbal blood glucose-lowering drugs are competent in creating hypoglycemia. Repaglinide ought to be managed with suppers to reduce the chance of hypoglycemia.
Storage Conditions
Do not store at temperatures above 30°C. Keep out of the reach of youngsters and away from light.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.